Login / Signup

Adjunctive Brexpiprazole for Patient Life Engagement in Major Depressive Disorder: A Canadian, Phase 4, Open-Label, Interventional Study.

François TherrienCaroline WardPratap ChokkaJeffrey HabertZahinoor IsmailRoger S McIntyreErin M MacKenzie
Published in: Canadian journal of psychiatry. Revue canadienne de psychiatrie (2024)
ClinicalTrials.gov identifier: NCT04830215.
Keyphrases
  • major depressive disorder
  • bipolar disorder
  • open label
  • social media
  • randomized controlled trial
  • phase ii